Current Osteoporosis Reports

, Volume 2, Issue 1, pp 24–30

Intravenous bisphosphonate therapy for osteoporosis: Where do we stand?

  • Henry G. Bone
  • Werner Schurr

DOI: 10.1007/s11914-004-0011-5

Cite this article as:
Bone, H.G. & Schurr, W. Curr Osteoporos Rep (2004) 2: 24. doi:10.1007/s11914-004-0011-5


The use of oral bisphosphonates, particularly members of the aminobisphosphonate subclass, is well established for the treatment of osteoporosis. In a number of clinical settings, intravenous administration appears to be advantageous. However, current dosing and efficacy data are limited while definitive, long-term trials with some of these agents are ongoing. In this article, we review the available information and discuss the use of these drugs on that basis.

Copyright information

© Current Science Inc. 2004

Authors and Affiliations

  • Henry G. Bone
    • 1
  • Werner Schurr
  1. 1.Michigan Bone and Mineral ClinicDetroitUSA